<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02767817</url>
  </required_header>
  <id_info>
    <org_study_id>CAS-XDA-BI/IGDB</org_study_id>
    <nct_id>NCT02767817</nct_id>
  </id_info>
  <brief_title>Injectable Collagen Scaffold™ Combined With MSCs Transplantation for Brain Injury</brief_title>
  <official_title>The Safety and Efficacy Assessment of Injectable Collagen Scaffold™ Combined With Mesenchymal Stem Cells Transplantation in Patients With Brain Injury</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Academy of Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Affiliated Hospital of Logistics University of CAPF</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chinese Academy of Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the safety and efficacy of injectable collagen
      scaffold combined with Mesenchymal stem cells (MSCs) transplantation in patients with brain
      injury.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of adverse events and participants with those adverse events</measure>
    <time_frame>24 month</time_frame>
    <description>Proportion of patients with postoperative infections and serious adverse events (SAEs) will be assessed by long term follow-up.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in functional outcomes as measured by National Institutes of Health stroke scale (NIHSS) score</measure>
    <time_frame>baseline, day 1-7, and 1, 3, 6, 12, 18 and 24 month after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in motor recovery evaluated by Brunnstrom stage</measure>
    <time_frame>1, 3, 6, 12, 18 and 24 month after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in self-care ability as measured by Barthel Index (BI)</measure>
    <time_frame>1, 3, 6, 12, 18 and 24 month after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pain intensity as measured by Visual Analogue Scale (VAS)</measure>
    <time_frame>1, 3, 6, 12, 18 and 24 month after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in electrical brain activity as measured by Electroencephalography (EEG)</measure>
    <time_frame>baseline, day 1, 4, 7, and 1, 3, 6, 12, 18, 24 month after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in brain electrophysiology as measured by Somatosensory evoked potential (SSEP)</measure>
    <time_frame>baseline, day 1,4,7, and 1, 3, 6, 12, 18, 24 month after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in brain pathology diagnosed by Head CT scan</measure>
    <time_frame>baseline, day 1,4,7, and 1, 3, 6, 12, 18, 24 month after surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Brain Injury</condition>
  <arm_group>
    <arm_group_label>Stereotactic Hematoma Evacuation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>MSCs Transplantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Injectable Collagen Scaffold with MSCs Transplantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stereotactic Hematoma Evacuation</intervention_name>
    <description>Stereotactic intracranial hematoma and insert the drainage tube to inhale haematoma. The drainage tube stayed in the position for 1-2 days until adequate drainage of hematomas, and then the drainage tube was pulled out.</description>
    <arm_group_label>Stereotactic Hematoma Evacuation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>MSCs Transplantation</intervention_name>
    <description>Stereotactic intracranial hematoma and insert the drainage tube to inhale haematoma. The drainage tube stayed in the position for 1-2 days until adequate drainage of hematomas,and 10 million MSCs were transplanted into the hematoma cavity before the drainage tube was pulled out.</description>
    <arm_group_label>MSCs Transplantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Injectable Collagen Scaffold with MSCs Transplantation</intervention_name>
    <description>Stereotactic intracranial hematoma and insert the drainage tube to inhale haematoma. The drainage tube stayed in the position for 1-2 days until adequate drainage of hematomas, and injectable collagen scaffold combined with 10 million MSCs were transplanted into the hematoma cavity before the drainage tube was pulled out.</description>
    <arm_group_label>Injectable Collagen Scaffold with MSCs Transplantation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Male or female，35-75 years old.

          2. The surgery time should be &gt; 6 hours after symptom onset.

          3. Glasgow coma score (GCS) was 9-15.

          4. CT diagnosis of intracerebral hemorrhage (25-40 ml), except for patients with signs of
             craniotomy to remove the hematoma.

          5. Signed informed consent obtained from the patient or patient's legally authorized
             representative.

        Exclusion Criteria:

          1. Glasgow coma scale of &lt;8.

          2. Patients suffering severe heart failure, severe lung disease, uremia, cirrhosis,
             end-stage cancer, coagulation disorders, stroke sequela.

          3. Asphyxia, cardiac arrest or successful cardiopulmonary resuscitation before
             hospitalization.

          4. Lactating or pregnant woman.

          5. Refuse to sign informed content.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jianwu Dai, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese Academy of Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zhifeng Xiao, Ph.D</last_name>
    <phone>86-10-82614420</phone>
    <email>zfxiao@genetics.ac.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sufang Han, Ph.D</last_name>
    <phone>86-10-82614420</phone>
    <email>sufanghan22@genetics.ac.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Affiliated Hospital of Logistics Universtiy of CAPF</name>
      <address>
        <city>Tianjin</city>
        <zip>300162</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yue Tu, M.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 29, 2016</study_first_submitted>
  <study_first_submitted_qc>May 9, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2016</study_first_posted>
  <last_update_submitted>May 9, 2016</last_update_submitted>
  <last_update_submitted_qc>May 9, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Academy of Sciences</investigator_affiliation>
    <investigator_full_name>Jianwu Dai</investigator_full_name>
    <investigator_title>Principal Investigator of Regenerative Medicine Laboratory, Institute of Genetics and Developmental Biology, CAS</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

